PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of plospathPLoS PathogensSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)View this Article
 
PLoS Pathog. Dec 2007; 3(12): e197.
Published online Dec 21, 2007. doi:  10.1371/journal.ppat.0030197
PMCID: PMC2151084
Discordant Evolution of the Adjacent Antiretroviral Genes TRIM22 and TRIM5 in Mammals
Sara L Sawyer,1 Michael Emerman,1,2 and Harmit S Malik1*
1 Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
2 Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America
Jeremy Luban, Editor
Institute for Research in Biomedicine, Switzerland
* To whom correspondence should be addressed. E-mail: hsmalik/at/fhcrc.org
Received August 30, 2007; Accepted November 6, 2007.
TRIM5α provides a cytoplasmic block to retroviral infection, and orthologs encoded by some primates are active against HIV. Here, we present an evolutionary comparison of the TRIM5 gene to its closest human paralogs: TRIM22, TRIM34, and TRIM6. We show that TRIM5 and TRIM22 have a dynamic history of gene expansion and loss during the evolution of mammals. The cow genome contains an expanded cluster of TRIM5 genes and no TRIM22 gene, while the dog genome encodes TRIM22 but has lost TRIM5. In contrast, TRIM6 and TRIM34 have been strictly preserved as single gene orthologs in human, dog, and cow. A more focused analysis of primates reveals that, while TRIM6 and TRIM34 have evolved under purifying selection, TRIM22 has evolved under positive selection as was previously observed for TRIM5. Based on TRIM22 sequences obtained from 27 primate genomes, we find that the positive selection of TRIM22 has occurred episodically for approximately 23 million years, perhaps reflecting the changing pathogenic landscape. However, we find that the evolutionary episodes of positive selection that have acted on TRIM5 and TRIM22 are mutually exclusive, with generally only one of these genes being positively selected in any given primate lineage. We interpret this to mean that the positive selection of one gene has constrained the adaptive flexibility of its neighbor, probably due to genetic linkage. Finally, we find a striking congruence in the positions of amino acid residues found to be under positive selection in both TRIM5α and TRIM22, which in both proteins fall predominantly in the β2-β3 surface loop of the B30.2 domain. Astonishingly, this same loop is under positive selection in the multiple cow TRIM5 genes as well, indicating that this small structural loop may be a viral recognition motif spanning a hundred million years of mammalian evolution.
The intrinsic immunity protein TRIM5α provides a post-entry defense against retroviral infection, which depends on its specific ability to recognize retroviral capsids. TRIM5α has been locked in genetic conflict with retroviruses throughout most of primate evolution, characterized by a higher than expected rate of amino acid change, referred to as positive selection. Here, we find that one of TRIM5's closest human paralogs, TRIM22, has also undergone positive selection in primates. However, we find that its close linkage to TRIM5 has resulted in an anti-correlated pattern of positive selection, with primate lineages generally showing positive selection in either TRIM5 or TRIM22, but not both. Amino acid positions in TRIM22 found to be under positive selection are in remarkable proximity to the “antiviral specificity patch” previously described for TRIM5α. TRIM5 and TRIM22 evolution appears to be equally discordant in other mammals; the cow genome contains an expanded cluster of TRIM5 genes and no TRIM22 gene, while the dog genome encodes TRIM22 but has lost TRIM5. Our analyses highlight TRIM22 as bearing all the evolutionary hallmarks of a candidate intrinsic immunity gene.
Humans and other primates encode several intracellular proteins that can potently inhibit retroviruses after they have entered target cells [16]. One such protein, TRIM5α, exists in highly dynamic cytoplasmic structures [7] and intercepts retroviruses through recognition of the retroviral CA (capsid) protein assembled onto a viral core [8], leading to accelerated uncoating of the viral particle [9]. Human TRIM5α can block some retroviruses, but has insufficient activity against HIV [10,11]. However, the TRIM5α protein encoded by rhesus monkeys and some other primates efficiently blocks HIV infection [10,1215]. Species specificity of TRIM5α for retroviruses can be altered by only a few amino acid changes in the coiled-coil and/or B30.2 protein domains [1618]. Both of these domains have been subject to positive selection in primates [16], confirming that the ongoing host-virus “arms race” is leading to rapid change at viral interaction surfaces. Thus, the species specificity currently observed in this restriction system has presumably resulted from evolutionary pressure exerted by previous or ongoing infections [11,16,19,20].
The human genome contains approximately 70 genes of the TRIM family, which characteristically encode a tri-partite protein motif (TRIM) [2123]. This motif consists of a “RING” zinc-coordinating domain, one or two zinc-coordinating “B-boxes,” and an alpha-helical “coiled-coil” motif (also referred to as the RBCC domains), whose order and spacing are conserved. RING domains are often associated with E3 ubiquitin ligases, and several TRIM proteins have been found to have such activity [2325]. Some members of the TRIM family form homo- and hetero-multimers predominantly via their coiled-coil domains [21]. Most TRIM genes also encode a variable C-terminal domain, and in over half of them, including the TRIM5α protein isoform of TRIM5, this is a B30.2 domain. While RING, coiled-coil, and B30.2 domains are also found in other protein families, the B-Box is a unique and defining domain of the TRIM family. The function of the B-box is unknown, but it is essential for restriction by TRIM5α [26,27], and mutations in the B-box have significant effects on the half-life of the TRIM5α protein [28]. Although TRIM genes are scattered throughout the human genome, TRIM5 sits in a small cluster of four closely related TRIM genes that also includes TRIM6, TRIM34, and TRIM22.
Most members of the human TRIM gene family remain functionally uncharacterized, or have so far tested negative for antiviral activity [29,30]. However, there are a few exceptions. The TRIM1 protein has been demonstrated to weakly restrict the murine retrovirus N-MLV [15,30]. There is mounting evidence that PML (TRIM19) encodes antiviral activity against diverse viruses, including herpes simplex type 1 (HSV-1), vesicular stomatitis virus (VSV), influenza A, and human cytomegalovirus (reviewed in [1,22]). Overexpression of TRIM34 has been shown to restrict HIV-2, SIVmac, and EIAV [29,30]. TRIM25 is involved in signal transduction leading to interferon production in response to RNA viruses [25]. Recent evidence has suggested that TRIM22 may also have antiviral properties, although there is some inconsistency between studies. For instance, overexpression of TRIM22 can inhibit spreading infection of HIV-1 in certain cell types, including macrophages [31], and TRIM22 may down-regulate transcription from the long terminal repeat promoter of HIV-1 [32]. However, TRIM22 does not restrict HIV-1 infection in alternate assays and cell types [29,30]. Like TRIM5α, TRIM22 expression is induced by interferon, as might be expected for an antiviral protein [3133]. Of this small collection of possible antiviral TRIM genes, TRIM34 and TRIM22 sit directly in the TRIM5 gene cluster.
The evolutionary “Red Queen” hypothesis addresses proteins which, like TRIM5α, are directly involved in antagonistic interactions with another genetic entity [34]. Under this hypothesis, TRIM5α will be continually selected for protein innovation in order to maintain fitness relative to retroviruses. A common measure for quantifying protein evolution is the dN/dS parameter, which summarizes the rate of amino acid–altering DNA changes relative to the baseline of “silent” DNA changes [35]. By looking at the DNA sequence of TRIM5 from multiple species, we were able to conclude that this gene has experienced accelerated protein evolution because of high dN/dS ratios [16]. In individual populations (like humans) the actual mechanism of positive selection is the selective sweep, where an advantageous mutation rises in frequency in the population by the forces of natural selection. However, this mutation will not rise in frequency alone, but will commonly bring along with it proximal mutations (good, bad, or neutral) as “hitchhikers.” Since TRIM5 has been under positive selection [16], we asked how this has affected its genomic neighborhood containing related TRIM genes with antiviral potential.
We show that the cow genome contains an expanded cluster of TRIM5 genes and no TRIM22 gene, while the dog genome encodes TRIM22 but has lost TRIM5. In contrast, TRIM6 and TRIM34 have been strictly preserved as single gene orthologs in these genomes. Based on TRIM22 sequence from 27 primate genomes, we find strong evidence of episodic positive selection in primate TRIM22 as was previously observed for TRIM5 [16]. However, we find that the evolutionary episodes of positive selection that have acted on TRIM5 and TRIM22 are mutually exclusive, with generally only one of these genes being positively selected in any given primate lineage. Finally, we find a striking congruence in the positions of amino acid residues found to be under positive selection in both TRIM5α and TRIM22, which in both proteins fall predominantly in the β2-β3 surface loop of the B30.2 domain.
Dynamic Evolution of the TRIM6/34/5/22 Gene Cluster in Mammals
While the ~70 TRIM genes are dispersed throughout the human genome, TRIM5 sits in a cluster of four TRIM genes located at 11p15.4, which also includes TRIM6, TRIM34, TRIM22, and one pseudogene called TRIMP1 (Figure 1A, top). Previous analyses have shown that these four TRIM genes are the closest human paralogs [29,36], indicating that this gene cluster probably arose through tandem gene duplication. We examined how TRIM5 and its closest paralogs have evolved in mammals using available genome projects (Baylor Bovine Genome Project, [37,38]). The human, cow, and dog TRIM6/34/5/22 gene clusters are illustrated in Figure 1A. In all three species, the gene cluster is flanked by tandem arrays of olfactory receptors, and is specifically preceded by OR52H1 and OR52B6 orthologs. We relied on neighbor-joining trees of RBCC protein sequences (Figure 1B) and DNA sequences (for pseudogenes and shortened genes, data not shown) to assign gene names by orthology, cognizant that the rapidly evolving B30.2 domain [16] may obfuscate true phylogenetic patterns. Bootstrap support for all four major clades is very strong (100%). Therefore we can clearly assign each cow and dog gene to a group orthologous to one of the four human TRIM genes.
Figure 1
Figure 1
Evolutionary Dynamics of the TRIM6/34/5/22 Cluster
The cow gene cluster on chromosome 15 contains eight TRIM5 genes, five of which encode predicted or validated ORFs. An additional TRIM5 ortholog, found on the cow chromosome 9, is predicted to encode an ORF of only the coiled-coil and B30.2 domains, although there is not yet evidence that it is expressed. This gene, TRIM5–9, is intron-less and is likely the result of a LINE-mediated cDNA integration (all cow and dog sequences can be found in Appendix S1). Inclusion on the tree of a TRIM5 gene from the pig genome shows that the cow TRIM5 expansion has occurred since cows diverged from their last common ancestor with pig (Figure 1B). Surprisingly, we do not find an ortholog of TRIM22 in the cow genome (Figure 1A, middle line). Instead, the chromosome 15 gene cluster terminates into a long string of olfactory receptors (at least eight) before the closest contig gap in the genome assembly. BLAST searches of the cow genome and transcript databases also did not uncover a TRIM22 ortholog, confirming our finding that the cow genome most likely lacks TRIM22.
In contrast, the dog cluster contains TRIM22 but lacks TRIM5. The dog TRIM5 gene has been disrupted by an insertion of the PNRC1 gene. Copies of PNRC1 reside both upstream and within the cluster, and these two PNRC1 genes are 98% identical at the DNA level (479/489 bases identical), suggesting a recently shared gene ancestor. Cryptic, pseudogenized remnants of TRIM5 exon 2 (encoding the RING and B-box2 domains) and exon 8 (encoding the B30.2 domain) were identified on either side of this gene (Figure 1A and Appendix S1). The absence of a functional TRIM5 gene elsewhere in the dog genome was confirmed by BLAST analysis of genomic and transcript databases. Interestingly, most in vitro studies on TRIM-mediated retroviral restriction have relied on either feline or canine cells as a “blank slate” cell line that has little intrinsic restriction against retroviruses [39]. It is tempting to speculate that this phenotype is dictated by the loss of TRIM5 genes in these species.
The opossum genome project is also suitably complete [40], but yielded no orthologs to these four genes. The most closely related TRIM gene in the opossum genome corresponds to human TRIM39, which in opossum is represented as an array of seven tandem, intron-less genes (data not shown). We can therefore date the TRIM6/34/5/22 gene cluster to after the divergence of eutherian (placentals) and metatherian (marsupial) mammals around 180 million years ago [40], but before the divergence of the major eutherian groups containing dog, cow, and human beginning approximately 90–100 million years ago [41]. In support of the eutherian origin of this gene cluster, we also find no orthologs of these four genes in the chicken genome [42]. The most parsimonious explanation for these data is that a common TRIM ancestor gene initially gave rise to this cluster between 90 and 180 million years ago. Of these, TRIM5 and TRIM22 continued to be subject to gene gain and loss, while TRIM6 and TRIM34 remained more static.
Positive Selection of Cow TRIM5 Genes
TRIM5 duplications have been retained in the cow genome, and of these, TRIM5–3 (previously known as LOC505265) has been shown to encode antiviral activity [36,43]. We can assess whether the TRIM5 gene expansion in cows has been accompanied by evolutionary diversification of new paralogs by looking at the evolutionary signatures that these genes have accumulated since divergence from their common ancestor, the original cow TRIM5 gene. We analyzed the evolution of the four full-length predicted or verified TRIM5 genes (TRIM5–1, TRIM5–3, TRIM5–4, TRIM5–6). A multiple sequence alignment of these four genes was analyzed under various models of codon evolution to assess the support for positive selection, using a maximum likelihood approach as implemented in the PAML program [44]. Under this approach, there are some models of evolution (M1, M7, and M8A) in which codons are allowed to evolve under variable selective pressures but are constrained to neutral or negative selection (dN/dS ≤ 1). In alternate models (M2, M8), an adjustment is made so that a subset of codons is permitted to evolve under positive selection (dN/dS > 1). A likelihood ratio test is used to assess whether a model of positive selection fits the data significantly better than one of the “null” models. Regardless of models compared, or of the parameters defining codon frequencies in these models (f3x4 or f61), we find strong support for a sub-class of codons evolving under positive selection (p < 0.001, Figure 2A). We find that 4.8% of the TRIM5 codons have an average dN/dS of 7.4. These data indicate that the four TRIM5 paralogs have been under positive selection, potentially to diversify their capsid-binding function after expansion.
Figure 2
Figure 2
Natural Selection of Cow TRIM5 Genes
To determine whether the bovine TRIM5–3 gene previously shown to restrict HIV [36,43] has been on a distinct evolutionary trajectory, we analyzed evolutionary signatures (dN/dS) along each branch of a tree representing these four cow paralogs (Figure 2B). Whole gene dN/dS values over 1.0 are considered extreme because they indicate that amino acid–altering mutations are being fixed in the gene even faster than neutral changes (in contrast, amino acid–altering DNA changes are usually poorly tolerated in protein-coding genes). Such large values of dN/dS represent the selection for protein innovation predicted to happen in arms race scenarios. The TRIM5–3 branch has the highest value of dN/dS (2.6), and this gene has accumulated 22 non-synonymous DNA changes and only three synonymous changes since the duplication that resulted in TRIM5–3 and TRIM5–6. The signature of TRIM5–6 is nearly as high (2.0), and even higher than TRIM5–3 when the B30.2 is analyzed separately (2.3 vs. 1.2). Signatures of positive selection along the TRIM5–4 and TRIM5–1 branches might be obscured due to the older divergence time of these genes (large dS values can make it difficult to detect positive selection). This analysis indicates that TRIM5–3 may not be unique among cow TRIM5s in its antiviral potential, although only one of these may encode anti-HIV activity, as TRIM5–6 has tested negative [36].
Positive Selection of TRIM22 in Primate Genomes
We have previously shown that TRIM5 gene sequence has been shaped by positive selection for over 30 million years of primate evolution, even predating the evolutionary origins of primate lentiviruses [16]. We wished to address whether TRIM6, TRIM34, and TRIM22 have also been evolving under a similar regime. Sliding window analysis of dN/dS along the length of these genes was used to identify gene regions subject to positive selection (data not shown, see [45] for method). This analysis was performed on TRIM6, TRIM34, and TRIM22 gene sequence obtained from the three sequenced primate genomes: human, chimpanzee, and rhesus macaque [38,46,47]. We found no evidence for positive selection of either TRIM6 or TRIM34 (p > 0.05) but strong evidence for TRIM22 (p < 0.05). Based on this result, we undertook a more extensive analysis of TRIM22 in primate genomes. We sequenced the protein-coding sequence of TRIM22 from six hominoids (HOM), seven old world monkeys (OWM), and eight new world monkeys (NWM) for a total of 21 full-length sequences representing 33 million years of primate divergence [48]. There is strong support for positive selection of TRIM22 in the HOM+OWM clade (p < 0.02, Table 1). This signature of positive selection (5% of codons fall into a category of dN/dS = 6.2) is similar to the signature observed in a matched-primate analysis of TRIM5 (6% of codons fall into a category of dN/dS = 6.3). This is remarkable, because TRIM5 has one of the most extreme signatures of positive selection in the human genome [16].
Table 1
Table 1
Positive Selection of TRIM22 and TRIM5
Despite the strong signature of positive selection in the HOM+OWM clade, there was no support for positive selection of TRIM22 in the NWM clade (p > 0.1, Table 1). The tree length (number of substitutions per codon) in the NWM clade (0.39) is greater than that of the HOM+OWM clade (0.32), suggesting that the lack of positive selection in the NWM clade is not a result of lower statistical power due to reduced evolutionary depth. The lack of positive selection in NWM TRIM22 is in stark contrast to NWM TRIM5, for which there is strong support for positive selection in a matched-primate analysis (p < 0.0001). Therefore, we can conclude that the positive selection of TRIM22 has predominantly occurred in OWM and hominoids, in contrast to the positive selection of TRIM5, which has occurred in all analyzed primates throughout their geographical ranges and evolutionary history.
Disparate Evolutionary Histories of TRIM5 and TRIM22 in Primates
Another important means to elucidate the evolutionary history of a gene is by analyzing how dN/dS patterns have changed over distinct evolutionary lineages. For instance, our analysis of positive selection in TRIM5 allowed us to conclude that TRIM5α's antiviral role is ancient but highly episodic [16]. We can now ask whether episodic selective pressures exerted by pathogens have simultaneously affected the evolution of both TRIM5 and TRIM22; in this scenario, one might expect to find a correlation in dN/dS values between TRIM5 and TRIM22 over time. To test this hypothesis, we calculated dN/dS values along each branch of the primate phylogeny for both TRIM22 and TRIM5, using the free-ratio model in PAML (see Methods).
In the NWM clade, branch dN/dS values are almost uniformly lower for TRIM22 than for TRIM5 (Figure 3A). This is to be expected, since in NWM evidence for positive selection is strong for TRIM5, but not for TRIM22 (Table 1). It is useful to ask whether fluctuations in branch dN/dS values truly represent changing selective pressures, or simply noise around an average value. We can address this issue by comparing the likelihood of a tree modeled with individual dN/dS values for each branch to the likelihood obtained when a single dN/dS is fitted onto the whole tree. Branch values on each of the TRIM22 and TRIM5 NWM trees are not significantly different from one another (Table 2), because a single universal dN/dS value cannot be statistically rejected (dN/dSuniversal is calculated as 0.45 for TRIM22 and 1.2 for TRIM5). Therefore, while two branches on the TRIM22 NWM tree have dN/dS values greater than 1, we can conclude that these deviations from the average dN/dS are not statistically significant. Together, these patterns suggest that, in NWM, predominantly uniform selective pressures have acted on both genes, but that positive selection has played a major role in shaping only TRIM5. This implies a functional difference between these two genes in the primates of the Americas, and suggests that TRIM5 may tend to be more commonly involved in pathogen protection than TRIM22 in these primates, in either its canonical form or as TRIM-Cyp [49].
Figure 3
Figure 3
Disparate Evolution of TRIM5 and TRIM22 in Primates
Table 2
Table 2
Statistical Analyses of Branch-Specific dN/dS Values
The situation is quite different in the HOM+OWM clade. In contrast to what we found in the NWM clade, episodic selection has acted on both TRIM22 and TRIM5 (p < 0.05, Table 2). Additionally, the branch-specific patterns of dN/dS for both TRIM5 and TRIM22 are quite different from one another (Figure 3B); branches with high values of dN/dS for one gene often have low values for the other gene. This is qualitatively illustrated by highlighting the ten branches on each tree that have the highest values of dN/dS (thick red branches, Figure 3B). Only two of these highlighted branches overlap between the two trees. The apparently inverse relationship between TRIM5 and TRIM22 dN/dS values can be tested with a rank-order correlation statistic, which supports a strong anti-correlation (r = −0.58, p < 0.01, Table 2). As a control, we find that dS values are correlated between the two genes (r = +0.38, p < 0.05, Table 2), as would be expected since dS is predominantly a function of evolutionary time represented by a given branch (the neutral mutation rate), whereas dN/dS represents the nature and intensity of selective constraint. dN/dS values for TRIM5 and TRIM22 are uncorrelated in NWM (r = −0.06, p = 0.43, Table 2), where branch-specific variability is not significant. In contrast to our initial hypothesis that episodic selective pressures may have simultaneously shaped these two closely related paralogs, this evidence suggests that TRIM5 and TRIM22 are anti-correlated in their evolutionary histories, and that usually only one of these genes appears to be subject to positive selection in any given lineage.
Broad Expression of TRIM5α and TRIM22 in Humans
One easy explanation for the anti-correlation in their evolutionary patterns is that TRIM5α and TRIM22 target distinct classes of viruses. Indeed, in single cycle assays for retroviral infection, TRIM22 was not found to restrict any of the retroviruses that TRIM5α restricts [30], even when TRIM22 orthologs from seven different primates were tested (our data not shown). To test the possibility that they might have distinct viral targets, we asked if these genes have evolved to produce unique expression patterns. Like many TRIM genes, TRIM5 mRNA is alternatively spliced, and three different protein isoforms have been reported, each successively shorter from the C-terminus. Only a single isoform has been reported for TRIM22, which is similar in structure to the alpha isoform of TRIM5 (TRIM5α), the longest TRIM5 isoform and the only one with antiviral activity. Primers were designed to amplify TRIM22 or TRIM5α transcripts from a panel of cDNA from different human tissues (Figure 4). We find that both TRIM5α and TRIM22 are expressed broadly in humans, and that the tissues where TRIM22 is expressed are for the most part a subset of tissues where TRIM5α is expressed. They are co-expressed in stimulated peripheral blood lymphocytes (PBL), which include the target cells for HIV and SIV, as well as in the testis, where heritable retroviral and retrotransposon insertions may provide a stringent selective pressure [11,16]. However, there also appear to be some tissues where only one of the two genes is strongly expressed. This opens the possibility that TRIM5α and TRIM22 have evolved differential expression because they each target distinct pathogens which infect different tissues. However, the model that distinct pathogenic targets has led to the evolutionary anti-correlation also requires that these different viral classes never or rarely challenge the same host simultaneously, an assumption that is difficult to defend.
Figure 4
Figure 4
Expression Patterns of Human TRIM22 and TRIM5α
Common TRIM22 and TRIM5α Amino Acid Sites Evolving under Positive Selection
The TRIM22 and TRIM5α proteins have a similar domain structure and share 58% amino acid identity (71% in the RING and B-box2 domains). These two proteins are most dissimilar in their coiled-coil and B30.2 domains, which include the retroviral recognition determinants mapped in TRIM5α [1618]. We investigated whether these putative retroviral recognition determinants have also accumulated the signatures of positive selection in TRIM22, utilizing the HyPhy and PAML programs to identify codons evolving under positive selection (see Methods). Since positive selection is limited to the HOM+OWM clade, only the 13 OWM and hominoid sequences were analyzed, with one NWM sequence (titi monkey) included as an outgroup. Addition of a single NWM sequence improves the statistical power of the analysis (data not shown). For the large eighth exon, which encodes the B30.2 domain, six additional OWM and hominoid sequences were obtained and included in the analysis, in order to provide maximum depth and residue detection in this critical domain. There is strong evidence for positive selection in all of these sequence sets (p < 0.001 for all model comparisons).
Ten TRIM22 codons have dN/dS values significantly greater than 1.0 (p > 0.95, Table S3), and these are schematically illustrated in Figure 5A. Of these, three codons lie in the encoded coiled-coil protein domain, in close proximity to the five positively selected sites previously documented in TRIM5α's coiled-coil domain (Figure 5B) [16]. The spatial similarity between sites identified for these two proteins suggests that there might be small segments of the coiled-coil that are especially relevant to viral interactions [17], even though it is predicted to form one long alpha-helical coil. The B30.2 domain consists strictly of tandem beta strands that fold into a beta-sandwich core [50,51]. Beta strands tend to be composed of conserved residues, while loops between beta strands are variable in both sequence and length [16,18,51]. Six of the ten positively selected sites in TRIM22 fall in the first part of the B30.2 domain, including four in the extended loop between beta strands 2 and 3 (Figure 5C). Surprisingly, the loop between strands 2 and 3 also corresponds to the location of the “patch” of HOM-OWM specific positive selection previously observed in TRIM5α (black horizontal bar [16]). Residues within this “patch” were shown to be the major specificity determinant of HIV recognition in TRIM5α [16,17,52]. Because of low sequence similarity in the loop between beta strands 2 and 3 (due in part to positive selection), exact TRIM5-TRIM22 sequence alignment is somewhat uncertain. However, it is intriguing that the TRIM22 residues identified show similar spacing to those of the TRIM5α patch. We can conclude that the positive selection of TRIM22 has been concentrated in the same regions as those responsible for retroviral specificity in TRIM5α.
Figure 5
Figure 5
TRIM22 Amino Acid Sites Identified as Evolving under Positive Selection
We also analyzed the four full-length TRIM5 genes from cow for codons under positive selection, where we find one codon identified with high confidence (p > 0.95). Amazingly, out of 470 codons analyzed, this site again falls directly in the β2-β3 loop of the B30.2 (Figure 5C). When the single known pig TRIM5 gene is included as an outgroup, an additional codon in this region can be identified (outlined box, Figure 5C). This loop has therefore been targeted by positive selection in the TRIM5 genes of both primates and cows. This, together with the identification of this loop in the analysis of primate TRIM22, illustrates the ancient importance of this small structural loop in the TRIM5/22-mediated arm of retroviral immunity.
Ancient Signatures of Positive Selection in the Primate TRIM22 Gene
We show here that powerful episodes of positive selection have acted on the TRIM22 antiretroviral gene. The Red Queen hypothesis suggests that this signature could have arisen from millions of years of interaction between the TRIM22 protein and viral pathogens. While several other TRIM genes are known to encode at least weak antiviral activity, TRIM5 is the only TRIM yet shown to possess such signatures [16,53], and now we find a second example with signatures of similar strength. It is possible that, while other TRIMs do have antiviral activity, TRIM5 and TRIM22 are unique in that they encode proteins that make direct physical contact with viral proteins, in contrast to indirectly affecting viral progression. While we know a significant amount regarding the importance and activity of TRIM5α against retroviruses, we know much less about the potential antiviral role of TRIM22. The present evolutionary analysis predicts that hominoid and old world monkey orthologs of TRIM22 have antiviral potential (based on strong signatures of positive selection), that they operate through similar mechanisms as TRIM5α (based on congruence of positions of positively selected sites), but that their substrate specificity has been uniquely tailored over time (based on the anti-correlation between TRIM5 and TRIM22 selective signatures). Although no definitive targets for TRIM22 have yet been described, one would not necessarily expect TRIM22 to have activity against modern retroviruses since the agent that led to the selective events may not currently be circulating exogenously [11].
Why Is TRIM5 Copy Number So Dynamic over Evolutionary Time?
The cow genome encodes multiple TRIM5 genes, while the dog genome encodes no TRIM5 at all. It is easy to imagine why TRIM5 may have duplicated so many times in cow, because multiple retroviral pathogens on different evolutionary trajectories essentially create multiple arms races in which TRIM5 genes must simultaneously engage. Thus, increasing the number of TRIM5 genes or alleles allows simultaneous selection for multiple retroviral affinities [20]. One possibility for the loss of TRIM5 in dog is that another, redundant gene has largely taken over TRIM5's antiretroviral function. In light of the current data it is tempting to speculate that this gene is TRIM22. Another possibility for the loss of TRIM5 from the dog genome is that retroviral pathogens have not provided a constant selective force for maintaining this gene. We have previously argued that relaxation of selective pressures may result in the loss of functional TRIM5 genes [19].
One of the TRIM5 genes in cow, TRIM5–3, was shown to act as a retroviral restriction factor [36,43]. However, because the identity of this gene was at the time unclear, it was concluded by one group [36] that cows evolved a unique, non-TRIM5 restriction factor from the TRIM gene family, in a scenario of convergent evolution in primates and cows. Here we definitively show that this gene is a cow ortholog of the human TRIM5 gene, and that the acquisition of a novel TRIM restriction factor was not an independent event in cows [54].
Anti-Correlated Evolution of Primate TRIM5 and TRIM22
We find both similarities and differences in the evolutionary histories of TRIM5 and TRIM22 in primates. Despite the similar footprints of positive selection left on both genes, it appears that either TRIM5 or TRIM22 has be subject to strong (and therefore detectable) positive selection in any given primate lineage, but rarely both. One easy explanation is that TRIM5α and TRIM22 target distinct classes of viruses, or even different variants of the same virus. When one of these viral classes or variants is predominating in the environment, the corresponding TRIM5 or TRIM22 gene evolves under positive selection. However, this model requires the assumption that these different viral types never or rarely challenge the same host simultaneously. Instead, we favor the alternate possibility that this discordance in their positive selection is a direct result of tight genetic linkage due to their neighboring positions. As positive selection acts on one gene (e.g., TRIM5) and drives a particular allelic variant to higher frequency in a population, two consequences will arise: linked mutations in nearby genes will “hitchhike” along with this advantageous allele, and overall sequence diversity in neighboring regions will be reduced as this single allele dominates. This is commonly known as the Hill-Robertson effect [55]. The net result is that selection is weakened in surrounding regions, making it more difficult for a neighboring gene (in this case, TRIM22) to be simultaneously subject to positive selection. Indeed, several studies have pointed out that genetic linkage can limit the power of natural selection, subjecting genomic neighborhoods to more stochastic (rather than selective) changes [5658].
Despite TRIM5 and TRIM22 being some of the most rapidly evolving primate genes, the possibility exists that a large portion of their adaptive landscape might still be unexplored if genetic linkage is dulling the power of selection on both. Additionally, since an adaptive event may require recurrent episodes of amino acid fixation, each gene may be slowed in its evolutionary “response time” to new pathogens. We propose that the Hill-Robertson effect may explain why large, related gene families (TRIM, olfactory receptors, etc.) tend to be broken up and scattered throughout genomes, because randomly occurring re-locations of single or groups of paralogous genes may be selectively favored in order to reduce recombinational “interference” between neighbors, and therefore to elicit maximal functional diversity from the family. A corollary of this prediction is that clusters that occur in genomic regions of high recombination may suffer fewer consequences of such interference. The APOBEC3 cytidine deaminases may be an example of such a gene cluster, as even neighboring genes appear to have undergone simultaneous positive selection in certain primate lineages [45,59]. The TRIM5 genes in cow may also be located in a recombinationally rich environment, since we observe simultaneous positive selection in several of these genes. Even with the limited information presented, there seems to be ample evidence of recombination in this region of the cow genome: loss of TRIM22, inversion of TRIM5 orientation relative to human, and expansion of the TRIM5 cluster since the cow-pig split.
Patterns of Positive Selection Highlight Common Motifs for Substrate Recognition
Our findings suggest that the “rules” for TRIM restriction of viruses may be quite well defined. Selection for beneficial mutations at the host-pathogen interface is predicted to cause rapid amino acid change specifically at the protein-protein interaction interface between host and viral proteins. Positive selection has acutely targeted the coiled-coil and B30.2 domains of both TRIM5α and TRIM22. Specific residues in the B30.2 define HIV recognition [1618], and the coiled-coil domain is also important for determining specificity to N-MLV [17]. The remarkable congruence in the positions of amino acid residues found to be under positive selection in both TRIM5α and TRIM22 suggests strongly that TRIM22 works through similar mechanisms of capsid recognition, and that the substrate recognition motifs will likely fall in the coiled-coil and B30.2 domains.
Surprisingly, our analyses continually identified the β2-β3 loop on the surface of the B30.2 domain [51,60] as an evolutionary hotspot, regardless of whether TRIM5 paralogs from cow, or TRIM5 and TRIM22 orthologs from primates, were analyzed. This loop is also referred to as Variable Loop 1 (VL1), and together VL1 and VL6 make up the PRY binding pocket in the highly related TRIM21 for which the crystal structure has been solved [51]. VL1 is important for substrate binding in TRIM21 (TRIM21 binds circulating antibodies and can cause auto-immune disease) and bears a major disease mutation in TRIM20/Pyrin [51]. This suggests that VL1 is a malleable substrate specificity domain, and can be selected for and against certain molecular affinities. While other regions of the B30.2 also contribute to retroviral specificity [60], this study emphasizes the long-standing importance of the β2-β3 structural loop in substrate recognition.
Characterizing dog and cow TRIM gene clusters.
The UCSC and NCBI databases were queried with available TRIM6/34/5/22 sequences to find all matches in the dog and cow genomes. These sequences were gathered and analyzed by phylogeny to establish gene families. PAUP (v4.0b10, [61]) was used to create and bootstrap neighbor-joining trees, and to create parsimony trees to verify relationships (data not shown). Pseudogenes and short ORFs (cow TRIM5–2,-5,-7,-8,-9) were confirmed as belonging to the TRIM5 clade by DNA-based phylogeny (data not shown). To rule out genome assembly errors, the cow region spanning from TRIM6 to TRIM5–6 is supported by the BAC clone AC149772. The RefSeq gene track tool on the UCSC database (http://www.genome.ucsc.edu/) was used to identify neighboring genes. Naming of cow and dog predicted olfactory receptor genes (“OR”) is based on the closest match in the human genome.
Sequencing of TRIM22 coding sequences from cDNA and genomic DNA.
Primate TRIM22 coding regions were sequenced either from genomic DNA (exons only) or from reverse transcribed mRNA. All primers and strategies used for amplification and sequencing are shown in Table S1. Primate DNA or cell samples were obtained from Coriell Cell Repositories (Camden, NJ) or from the Center for Reproduction of Endangered Species FrozenZoo Project (San Diego Zoo, San Diego, CA) and a list of primate species and sample numbers is shown in Table S2. PCR and RT-PCR products were sequenced directly, except in a few cases (denoted in primer table) where they were first cloned into the TOPO TA cloning vector (Invitrogen), followed by sequencing of independent clones. PCR from genomic DNA was performed with PCR Supermix High Fidelity (Invitrogen). RT-PCR from RNA was performed with the Superscript One-Step kit (Invitrogen) using RNA prepared with the RNeasy kit (Qiagen). Exon reads from genomic DNA were spliced together to create virtual transcripts. Exon structure was confirmed by full sequencing of RT-PCR products for the following primates: human, chimpanzee, gibbon, gorilla, orangutan, patas monkey, rhesus macaque, African green monkey, titi, tamarin, spider monkey, and woolly monkey. Alternately spliced transcripts of TRIM22 were detected only in orangutan (data not shown). Virtual transcripts and cDNA sequences have been entered into the GenBank database (http://www.ncbi.nlm.nih.gov/Genbank/index.html), and accession numbers (EU124690– EU124716) are detailed in Table S2.
PAML analysis of codon and lineage dN/dS values.
DNA sequences were aligned using Clustal_X [62] and PAL2NAL [63]. The codeml program in the PAML 3.14.1 package [44,64] was used to obtain maximum likelihood estimates for different models of codon evolution (see next section). The phylogeny of primate sequences was modeled as the currently accepted relationship for primates [48], which is the same tree as is derived from the TRIM22 and TRIM5 sequences with the exception of a few unresolved nodes. In order to ensure convergence of parameter optimization, each simulation was run with multiple seed dN/dS values. Each simulation was also run with two different models of codon frequencies, one referencing a 3x4 codon frequency table, and one in which the frequency of each of the 61 non-stop codons is empirically derived from the dataset. Identification of codon positions subject to positive selection was performed with codeml and with the random effects likelihood (REL) method of the HyPhy program [65,66]. Table S3 lists posterior probabilities for codon sites identified by PAML and HyPhy. A free ratio model (model = 1, one dN/dS per branch) was run in codeml to assess branch-specific values of dN/dS. This model also predicts the actual number of replacement and synonymous changes that occur along each branch. These values are in good agreement with changes assigned through parsimony (data not shown).
Statistical analyses.
Likelihood ratio tests (LRTs) were performed to compare different models simulated with PAML. Codon models of neutral/negative selection (dN/dS of all codons bounded between 0 and 1) were compared to models of positive selection (models where an additional class of codons with dN/dS >1 is allowed). Three such comparisons were made: M1 vs. M2, M7 vs. M8, and M8A vs. M8, where M1, M7, and M8A are neutral/negative models and M2 and M8 are positive selection models. Models M1 and M2 assume that all codons fall into a few discrete categories of dN/dS, while models M7, M8, and M8A utilize a more fluid beta-distribution to model codon dN/dS values. Model M8A differs from M8 in that it allows an extra class of codons to evolve at dN/dS = 1. Model M8A was implemented as previously described [67]. LRTs were also used to assess whether a free ratio model (different dN/dS for each branch) fit the data better than a one ratio model (universal dN/dS for all branches). The Spearman's Rank Correlation test (performed with InStat, GraphPad Software, San Diego, CA) was used to determine the degree of correlation between branch values for the TRIM22 and TRIM5 datasets. For correlation of dS values, all branch data was used. For correlation of dN/dS values, a few branches where one or both genes had values of infinity (dS = 0) were not included, as values must be finite for this test. For both tests, one-tailed p-values were reported.
Secondary structure predictions.
Protein sequences were submitted for secondary structure prediction on the JPRED server (http://www.compbio.dundee.ac.uk/~www-jpred/) [68].
Expression profiles of TRIM genes.
Primers were designed to recognize TRIM5α and TRIM22 transcripts and are listed in Table S1. In both cases, primers amplify about 600bp of the coiled-coil B30.2 gene region, and therefore the TRIM5 primers specifically recognize the alpha transcript. These primers were used to amplify cDNA from 31 human tissues on PrimExpress Human Normal Tissue cDNA Panels (PrimGen, Bothell, WA). The cDNA on this panel has been optimized for equal amplification of a ubiquitously expressed microglobulin gene (PrimGen product literature). We utilized PCR Supermix (Invitrogen, 10790–020) for amplification reactions and amplified through 49 PCR cycles.
Supporting Information
Appendix S1: Cow and Dog TRIM6/34/5/22 Sequences
(39 KB DOC)
Table S1: PCR, RT-PCR, and Sequencing Primers Used in This Study
(66 KB XLS)
Table S2: Summary of Primate Samples Used in This Study
(22 KB XLS)
Table S3: TRIM22 Codons under Positive Selection, Identified by HyPhy and PAML
(16 KB XLS)
Acknowledgments
We wish to thank Mark Deinert for assistance with statistical analyses, Nels Elde, Julie Kerns, and Eric Smith for helpful comments on the manuscript, and the UCSC genome bioinformatics group, NCBI, and the Baylor Bovine Genome Project for maintenance of genome databases. We are also grateful to Coriell, FrozenZoo (now IPBIR), Cristian Apetrei, and Evan Eichler for primate samples.
Footnotes
Author contributions. SLS, ME, and HSM conceived and designed the experiments. SLS, ME, and HSM performed the experiments. SLS, ME, and HSM analyzed the data. SLS, ME, and HSM contributed reagents/materials/analysis tools. SLS, ME, and HSM wrote the paper.
Funding. This work was initiated using funds from the American Foundation for AIDS Research (amfAR grant 106622–38-RGHF-MALIK). SLS was supported by a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund, and by NIH F32 GM074299. ME was funded by NIH R37 AI30927. HSM was funded by a Searle Scholar Award and a Burroughs Wellcome Investigator in Pathogenesis award. Funding agencies had no direct role in the design and conduct of the study or in the preparation, review, or approval of the manuscript.
Competing interests. The authors have declared that no competing interests exist.
  • Towers GJ. The control of viral infection by tripartitews motif proteins and cyclophilin A. Retrovirology. 2007;4:40. [PMC free article] [PubMed]
  • Malim MH. Natural resistance to HIV infection: the Vif–APOBEC interaction. C R Biol. 2006;329:871–875. [PubMed]
  • Perez O, Hope TJ. Cellular restriction factors affecting the early stages of HIV replication. Curr HIV/AIDS Rep. 2006;3:20–25. [PubMed]
  • Newman RM, Johnson WE. A brief history of TRIM5alpha. AIDS Rev. 2007;9:114–125. [PubMed]
  • Bieniasz PD. Intrinsic immunity: a front-line defense against viral attack. Nat Immunol. 2004;5:1109–1115. [PubMed]
  • Goff SP. Retrovirus restriction factors. Mol Cell. 2004;16:849–859. [PubMed]
  • Campbell EM, Dodding MP, Yap MW, Wu X, Gallois-Montbrun S, et al. TRIM5alpha cytoplasmic bodies are highly dynamic structures. Mol Biol Cell. 2007;18:2102–2111. [PMC free article] [PubMed]
  • Sebastian S, Luban J. TRIM5alpha selectively binds a restriction-sensitive retroviral capsid. Retrovirology. 2005;2:40. [PMC free article] [PubMed]
  • Stremlau M, Perron M, Lee M, Yuan L, Song B, et al. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc Natl Acad Sci U S A. 2006;103:5514–5519. [PubMed]
  • Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, et al. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature. 2004;427:848–853. [PubMed]
  • Kaiser SM, Malik HS, Emerman M. Restriction of an extinct retrovirus by the human TRIM5alpha antiviral protein. Science. 2007;316:1756–1758. [PubMed]
  • Hatziioannou T, Perez-Caballero D, Yang A, Cowan S, Bieniasz PD. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proc Natl Acad Sci U S A. 2004;101:10774–10779. [PubMed]
  • Keckesova Z, Ylinen LM, Towers GJ. The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc Natl Acad Sci U S A. 2004;101:10780–10785. [PubMed]
  • Perron MJ, Stremlau M, Song B, Ulm W, Mulligan RC, et al. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proc Natl Acad Sci U S A. 2004;101:11827–11832. [PubMed]
  • Yap MW, Nisole S, Lynch C, Stoye JP. TRIM5alpha protein restricts both HIV-1 and murine leukemia virus. Proc Natl Acad Sci U S A. 2004;101:10786–10791. [PubMed]
  • Sawyer SL, Wu LI, Emerman M, Malik HS. Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. Proc Natl Acad Sci U S A. 2005;102:2832–2837. [PubMed]
  • Yap MW, Nisole S, Stoye JP. A single amino acid change in the SPRY domain of human TRIM5alpha leads to HIV-1 restriction. Curr Biol. 2005;15:73–78. [PubMed]
  • Stremlau M, Perron M, Welikala S, Sodroski J. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction. J Virol. 2005;79:3139–3145. [PMC free article] [PubMed]
  • Sawyer SL, Wu LI, Akey JM, Emerman M, Malik HS. High frequency retention of an impaired allele of the retroviral defense gene TRIM5alpha in humans. Current Biology. 2006;16:95–100. [PubMed]
  • Newman RM, Hall L, Cannole M, Chen G, Sato S, et al. Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5alpha. Proc Natl Acad Sci U S A. 2006;103:19134–19139. [PubMed]
  • Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, et al. The tripartite motif family identifies cell compartments. Embo J. 2001;20:2140–2151. [PubMed]
  • Nisole S, Stoye JP, Saib A. TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol. 2005;3:799–808. [PubMed]
  • Meroni G, Diez-Roux G. TRIM/RBCC, a novel class of ‘single protein RING finger' E3 ubiquitin ligases. Bioessays. 2005;27:1147–1157. [PubMed]
  • Xu L, Yang L, Moitra PK, Hashimoto K, Rallabhandi P, et al. BTBD1 and BTBD2 colocalize to cytoplasmic bodies with the RBCC/tripartite motif protein, TRIM5delta. Exp Cell Res. 2003;288:84–93. [PubMed]
  • Gack MU, Shin YC, Joo CH, Urano T, Liang C, et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature. 2007;446:916–920. [PubMed]
  • Javanbakht H, Diaz-Griffero F, Stremlau M, Si Z, Sodroski J. The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5alpha. J Biol Chem. 2005;280:26933–26940. [PubMed]
  • Perez-Caballero D, Hatziioannou T, Yang A, Cowan S, Bieniasz PD. Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity. J Virol. 2005;79:8969–8978. [PMC free article] [PubMed]
  • Diaz-Griffero F, Kar A, Perron M, Xiang SH, Javanbakht H, et al. Modulation of retroviral restriction and proteasome inhibitor-resistant turnover by changes in the TRIM5alpha B-box 2 domain. J Virol. 2007;81:10362–10378. [PMC free article] [PubMed]
  • Li X, Gold B, O'hUigin C, Diaz-Griffero F, Song B, et al. Unique features of TRIM5alpha among closely related human TRIM family members. Virology. 2007;360:419–433. [PubMed]
  • Zhang F, Hatziioannou T, Perez-Caballero D, Derse D, Bieniasz PD. Antiretroviral potential of human tripartite motif-5 and related proteins. Virology. 2006;353:396–409. [PubMed]
  • Bouazzaoui A, Kreutz M, Eisert V, Dinauer N, Heinzelmann A, et al. Stimulated trans-acting factor of 50 kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages. Virology. 2006;356:79–94. [PubMed]
  • Tissot C, Mechti N. Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression. J Biol Chem. 1995;270:14891–14898. [PubMed]
  • Asaoka K, Ikeda K, Hishinuma T, Horie-Inoue K, Takeda S, et al. A retrovirus restriction factor TRIM5alpha is transcriptionally regulated by interferons. Biochem Biophys Res Commun. 2005;338:1950–1956. [PubMed]
  • Van Valen L. A new evolutionary law. Evolutionary Theory. 1973;1:1–30.
  • Holmes EC. Adaptation and immunity. PLoS Biol. 2004. e307 doi: 10.1371/journal.pbio.0020307. [PMC free article] [PubMed]
  • Si Z, Vandegraaff N, O'huigin C, Song B, Yuan W, et al. Evolution of a cytoplasmic tripartite motif (TRIM) protein in cows that restricts retroviral infection. Proc Natl Acad Sci U S A. 2006;103:7454–7459. [PubMed]
  • Lindblad-Toh K, Wade CM, Mikkelsen TS, Karlsson EK, Jaffe DB, et al. Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature. 2005;438:803–819. [PubMed]
  • Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409:860–921. [PubMed]
  • Towers G, Bock M, Martin S, Takeuchi Y, Stoye JP, et al. A conserved mechanism of retrovirus restriction in mammals. Proc Natl Acad Sci U S A. 2000;97:12295–12299. [PubMed]
  • Mikkelsen TS, Wakefield MJ, Aken B, Amemiya CT, Chang JL, et al. Genome of the marsupial Monodelphis domestica reveals innovation in non-coding sequences. Nature. 2007;447:167–177. [PubMed]
  • Hedges SB. The origin and evolution of model organisms. Nat Rev Genet. 2002;3:838–847. [PubMed]
  • Hillier LW, Miller W, Birney E, Warren W, Hardison RC, et al. Sequence and comparative analysis of the chicken genome provide unique perspectives on vertebrate evolution. Nature. 2004;432:695–716. [PubMed]
  • Ylinen LM, Keckesova Z, Webb BL, Gifford RJ, Smith TP, et al. Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals. J Virol. 2006;80:7332–7338. [PMC free article] [PubMed]
  • Nielsen R, Yang Z. Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics. 1998;148:929–936. [PubMed]
  • Sawyer SL, Emerman M, Malik HS. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol. 2004. e275 doi: 10.1371/journal.pbio.0020275. [PMC free article] [PubMed]
  • Gibbs RA, Rogers J, Katze MG, Bumgarner R, Weinstock GM, et al. Evolutionary and biomedical insights from the rhesus macaque genome. Science. 2007;316:222–234. [PubMed]
  • Mikkelsen TS, Hillier LW, Eichler EE, Zody MC, Jaffe DB, et al. Initial sequence of the chimpanzee genome and comparison with the human genome. Nature. 2005;437:69–87. [PubMed]
  • Purvis A. A composite estimate of primate phylogeny. Philos Trans R Soc Lond B Biol Sci. 1995;348:405–421. [PubMed]
  • Sayah DM, Sokolskaja E, Berthoux L, Luban J. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature. 2004;430:569–573. [PubMed]
  • Grütter C, Briand C, Capitani G, Mittl PR, Papin S, et al. Structure of the PRYSPRY-domain: implications for autoinflammatory diseases. Febs Lett. 2006;580:99–106. [PubMed]
  • James LC, Keeble AH, Khan Z, Rhodes DA, Trowsdale J. Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function. Proc Natl Acad Sci U S A. 2007;104:6200–6205. [PubMed]
  • Li Y, Li X, Stremlau M, Lee M, Sodroski J. Removal of arginine 332 allows human TRIM5alpha to bind human immunodeficiency virus capsids and to restrict infection. J Virol. 2006;80:6738–6744. [PMC free article] [PubMed]
  • Ortiz M, Bleiber G, Martinez R, Kaessmann H, Telenti A. Patterns of evolution of host proteins involved in retroviral pathogenesis. Retrovirology. 2006;3:1–7. [PMC free article] [PubMed]
  • Schaller T, Hue S, Towers GJ. An active TRIM5 in rabbits indicates an antiviral common ancestor for mammalian TRIM5 proteins. J Virol. 2007;81:11713–11721. [PMC free article] [PubMed]
  • Felsenstein J. The evolutionary advantage of recombinaton. Genetics. 1974;78:737–756. [PubMed]
  • Comeron JM, Kreitman M. Population, evolutionary and genomic consequences of interference selection. Genetics. 2002;161:389–410. [PubMed]
  • Betancourt AJ, Presgraves DC. Linkage limits the power of natural selection in Drosophila. Proc Natl Acad Sci U S A. 2002;99:13616–13620. [PubMed]
  • Presgraves DC. Recombination enhances protein adaptation in Drosophila melanogaster. Curr Biol. 2005;15:1651–1656. [PubMed]
  • OhAinle M, Kerns JA, Malik HS, Emerman M. Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H. J Virol. 2006;80:3853–3862. [PMC free article] [PubMed]
  • Ohkura S, Yap MW, Sheldon T, Stoye JP. All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction. J Virol. 2006;80:8554–8565. [PMC free article] [PubMed]
  • Swofford DL. PAUP*. Phylogenetic Analysis using parsimony (*and other methods), version 4. Sunderland (Massachusetts): Sinauer Associates; 2003.
  • Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 1997;25:4876–4882. [PMC free article] [PubMed]
  • Suyama M, Torrents D, Bork P. PAL2NAL: robust conversion of protein sequence alignments into the corresponding codon alignments. Nucleic Acids Res. 2006. pp. W609–W612. [PMC free article] [PubMed]
  • Yang Z. PAML: A program package for phylogenetic analysis by maximum likelihood. Comput Appl Biosci. 1997;13:555–556. [PubMed]
  • Pond SLK, Frost SDW, Muse SV. HyPhy: hypothesis testing using phylogenies. Bioinformatics. 2005;21:676–679. [PubMed]
  • Pond SLK, Frost SDW. Datamonkey: rapid detection of selective pressure on individual sites of codon alignments. Bioinformatics. 2005;21:2531–2533. [PubMed]
  • Swanson WJ, Nielsen R, Yang Q. Pervasive adaptive evolution in mammalian fertilization proteins. Mol Biol Evol. 2003;20:18–20. [PubMed]
  • Cuff JA, Clamp ME, Siddiqui AS, Finlay M, Barton GJ. JPred: a consensus secondary structure prediction server. Bioinformatics. 1998;14:892–893. [PubMed]
Articles from PLoS Pathogens are provided here courtesy of
Public Library of Science